Tag
Anuh Pharma Limited
2 articles
Anuh Pharma Q4 FY26 Investor Presentation Highlights
Anuh Pharma reported FY26 revenue of ₹776 Cr, a 15.66% YoY increase, driven by strong volume growth and expansion into regulated markets.
The company successfully completed USFDA and EU GMP inspection
Anuh Pharma Applies for 0.95% Promoter Group Reclassification
Anuh Pharma applied to stock exchanges to reclassify nine persons from Promoter Group to Public category under SEBI LODR Regulation 31A.
The reclassification request covers a total of 949,988 equity s